3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
2
Rhabdoid Tumor
1
Recurrence
1
Pinealoma
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Medulloblastoma
1
Glioma
1
Ependymoma
1
Diffuse Intrinsic Pontine Glioma
1
Choroid Plexus Carcinoma
1
Central Nervous System Neoplasms
1
Brain Neoplasms
1
Interventions
Bevacizumab
55
Cetuximab
52
Fluorouracil
45
Oxaliplatin
39
Leucovorin
37
pembrolizumab
34
Specimen Handling
28
Irinotecan
25
Nivolumab
17
Magnetic Resonance Spectroscopy
17
Biopsy
17
Capecitabine
14
trifluridine tipiracil drug combination
13
HMPL-013
13
Folfox protocol
13
Panitumumab
12
Gemcitabine
12
Cisplatin
12
Carboplatin
11
balstilimab
9
Standard of Care
9
Pemetrexed
9
IFL protocol
9
encorafenib
8
Trifluridine
8
Paclitaxel
8
Early Intervention, Educational
8
130-nm albumin-bound paclitaxel
8
fludarabine
7
atezolizumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
Automobiles
×
90 days
×
Clear all
No trials found.